240 related articles for article (PubMed ID: 16913276)
1. Atopic dermatitis or hyper-IgE syndrome?
Ohameje NU; Loveless JW; Saini SS
Allergy Asthma Proc; 2006; 27(3):289-91. PubMed ID: 16913276
[TBL] [Abstract][Full Text] [Related]
2. Role of omalizumab in a patient with hyper-IgE syndrome and review dermatologic manifestations.
Chularojanamontri L; Wimoolchart S; Tuchinda P; Kulthanan K; Kiewjoy N
Asian Pac J Allergy Immunol; 2009 Dec; 27(4):233-6. PubMed ID: 20232578
[TBL] [Abstract][Full Text] [Related]
3. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
[TBL] [Abstract][Full Text] [Related]
4. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
[TBL] [Abstract][Full Text] [Related]
5. Acute disseminated encephalomyelitis: an uncommon presentation of hyper IgE syndrome.
Purkait R; Kar S; Bhadra R; Sinhamahapatra T
J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S256-8. PubMed ID: 25518794
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.
Sheinkopf LE; Rafi AW; Do LT; Katz RM; Klaustermeyer WB
Allergy Asthma Proc; 2008; 29(5):530-7. PubMed ID: 18926061
[TBL] [Abstract][Full Text] [Related]
7. Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome.
Sogkas G; Hirsch S; Jablonka A; Witte T; Schmidt RE; Atschekzei F
Clin Immunol; 2020 Jun; 215():108452. PubMed ID: 32360519
[No Abstract] [Full Text] [Related]
8. Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experience.
Joshi AY; Iyer VN; Boyce TG; Hagan JB; Park MA; Abraham RS
Allergy Asthma Proc; 2009; 30(1):23-7. PubMed ID: 19331717
[TBL] [Abstract][Full Text] [Related]
9. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
10. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis.
Kasap N; Celik V; Isik S; Cennetoglu P; Kiykim A; Eltan SB; Nain E; Ogulur I; Baser D; Akkelle E; Celiksoy MH; Kocamis B; Cipe FE; Yucelten AD; Karakoc-Aydiner E; Ozen A; Baris S
Clin Immunol; 2021 Feb; 223():108645. PubMed ID: 33301882
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.
Schimke LF; Sawalle-Belohradsky J; Roesler J; Wollenberg A; Rack A; Borte M; Rieber N; Cremer R; Maass E; Dopfer R; Reichenbach J; Wahn V; Hoenig M; Jansson AF; Roesen-Wolff A; Schaub B; Seger R; Hill HR; Ochs HD; Torgerson TR; Belohradsky BH; Renner ED
J Allergy Clin Immunol; 2010 Sep; 126(3):611-7.e1. PubMed ID: 20816194
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis.
Incorvaia C; Pravettoni C; Mauro M; Yacoub MR; Tarantini F; Riario-Sforza GG
Monaldi Arch Chest Dis; 2008 Jun; 69(2):78-80. PubMed ID: 18837422
[TBL] [Abstract][Full Text] [Related]
13. Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab.
Nihal A; Comstock JR; Holland KE; Singh AM; Seroogy CM; Arkin LM
Pediatr Dermatol; 2022 Nov; 39(6):940-942. PubMed ID: 35734823
[TBL] [Abstract][Full Text] [Related]
14. Patient with atopic dermatitis, hyper IgE syndrome and ulcerative colitis, treated successfully with dupilumab during pregnancy.
Gracia-Darder I; Pons De Ves J; Reyero Cortina M; Martín-Santiago A
Dermatol Ther; 2022 Feb; 35(2):e15237. PubMed ID: 34850510
[No Abstract] [Full Text] [Related]
15. Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome.
Alonso-Bello CD; Jiménez-Martínez MDC; Vargas-Camaño ME; Hierro-Orozco S; Ynga-Durand MA; Berrón-Ruiz L; Alcántara-Montiel JC; Santos-Argumedo L; Herrera-Sánchez DA; Lozano-Patiño F; Castrejón-Vázquez MI
Case Reports Immunol; 2019; 2019():6357256. PubMed ID: 31355024
[TBL] [Abstract][Full Text] [Related]
16. [Hyper IgE syndrome. Opportune diagnosis and management].
Orozco CV; Velásquez LH; Méndez NH; Augusto B; Salazar T
Rev Alerg Mex; 2008; 55(1):38-45. PubMed ID: 18697452
[TBL] [Abstract][Full Text] [Related]
17. Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.
Amrol D
South Med J; 2010 Jun; 103(6):554-8. PubMed ID: 20710140
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab treatment in severe adult atopic dermatitis.
Thaiwat S; Sangasapaviliya A
Asian Pac J Allergy Immunol; 2011 Dec; 29(4):357-60. PubMed ID: 22299316
[TBL] [Abstract][Full Text] [Related]
19. Wanted: A study with omalizumab to determine the role of IgE-mediated pathways in atopic dermatitis.
Beck LA; Saini S
J Am Acad Dermatol; 2006 Sep; 55(3):540-1; author reply 541-2. PubMed ID: 16908373
[No Abstract] [Full Text] [Related]
20. [Omalizumab as a therapeutic option in atopic eczema. Current evidence and potential benefit].
Schmitt J; Schäkel K
Hautarzt; 2007 Feb; 58(2):128, 130-2. PubMed ID: 17237929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]